M&A Deal Summary

Orkla Acquires NutraQ

On June 15, 2021, Orkla acquired medical products company NutraQ from Impilo

Acquisition Highlights
  • This is Orkla’s 1st transaction in the Medical Products sector.
  • This is Orkla’s 1st transaction in Norway.

M&A Deal Summary

Date 2021-06-15
Target NutraQ
Sector Medical Products
Buyer(s) Orkla
Sellers(s) Impilo
Deal Type Add-on Acquisition

Target

NutraQ

Oslo, Norway
NutraQ is a provider of subscription-based health and wellness products in the Nordic region. NutraQ was founded in 2002 and is based in Oslo, Norway.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Orkla

Oslo, Norway

Category Company
Sector Retail
Employees19,080
Revenue 70.7B NOK (2024)
DESCRIPTION

Orkla is a provider of branded consumer goods and concept solutions to the grocery, out-of-home and bakery markets in the Nordics, the Baltics and selected markets in Central Europe and India. Orkla was founded in 1918 and is based in Oslo, Norway.


DEAL STATS #
Overall 6 of 7
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 6 of 7
Country: Norway M&A 1 of 1
Year: 2021 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-04 Dermika

Radzymin, Poland

Dermika offers premium face care cosmetics, complemented by a range of body care products. Dermika is based in Radzymin, Poland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-13 Hans Kaspar

Zufikon, Switzerland

Hans Kaspar is a specialist in the manufacture of specialty ingredients for chocolate and ice cream producers. Hans Kaspar was founded in 1925 and is based in Zufikon, Switzerland.

Buy -

Seller(S) 1

DESCRIPTION

Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Norway M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-20 Scantox

Lille Skensved, Denmark

Scantox is a GLP (“Good Laboratory Practice”) accredited CRO, providing pre-clinical research services, including regulatory in-vivo toxicology studies, that are critical to any drug development process. Scantox was founded in 1977 and is based in Lille Skensved, Denmark.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-03 tandlægen

Lyngby, Denmark

tandlægen is a dental care chain, that comprises 52 clinics across all regions in Denmark, employs over 800 professionals and serves more than a quarter of a million patients per year. tandlægen was formed in 2016 and is based in Lyngby, Denmark.

Buy -